Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer

Open access

Abstract

Targeted drug delivery using multifunctional polymeric nanocarriers is a modern approach for cancer therapy. Our purpose was to prepare targeted nanogels for selective delivery of chemotherapeutic agent cisplatin to luteinizing hormone-releasing hormone (LHRH) receptor overexpressing tumor in vivo. Building blocks of such delivery systems consisted of innovative soft block copolymer nanogels with ionic cores serving as a reservoir for cisplatin (loading 35%) and a synthetic analogue of LHRH conjugated to the nanogels via poly(ethylene glycol) spacer. Covalent attachment of (D-Lys6)-LHRH to nanogels was shown to be possible without loss in either the ligand binding affinity or the nanogel drug incorporation ability. LHRH-nanogel accumulation was specific to the LHRH-receptor positive A2780 ovarian cancer cells and not toward LHRH-receptor negative SKOV-3 cells. The LHRH-nanogel cisplatin formulation was more effective and less toxic than equimolar doses of free cisplatin or untargeted nanogels in the treatment of receptor-positive ovarian cancer xenografts in mice. Collectively, the study indicates that LHRH mediated nanogel-cisplatin delivery is a promising formulation strategy for therapy of tumors that express the LHRH receptor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/mp4003688

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 2

  1. Oberoi H. S., 2012, Chemother. Res. Pract., 2012, 905796
  2. Segal E., 1985, Cancer Res., 45, 492

Cited by

See all 63

Metadata

Authors
Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K.
Affiliations
  • Lomonosov Moscow State University (RU)
  • Nebraska Medical Center (US)
  • Pirogov Russian National Research Medical University (RU)
Corresponding author
  • Kabanov, Alexander V.
  • Bronich, Tatiana K.
Venue
Molecular Pharmaceutics
Published
2013-08-30
Volume
10
Issue
10
Pages
3913-3921
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2070912023
Cited by
63
References
32
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 1
FWCI
2.67
Type
journal article
Language
en
Open access
Locations
  • Molecular Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (CA116590, R01CA116590)
  • National Institute of General Medical Sciences (P20GM103480)
  • National Center for Research Resources (P20RR021937)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
nanogels, cisplatin, ovarian cancer, luteinizing hormone-releasing hormone receptor, polyethylene glycol spacer, A2780 cells, SKOV3 cells, xenografts, chemotherapy toxicity
MeSH terms
Nanogels, Animals, Antineoplastic Agents, Cisplatin, Female, Flow Cytometry, Humans, Mice, Nude, Ovarian Neoplasms, Polyethylene Glycols, Polyethyleneimine, Drug Delivery Systems, Microscopy, Confocal, Cell Line, Tumor, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer. https://app.cochat.ai/papers/10.1021/mp4003688
The paper
Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K. (2013). LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/mp4003688

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.